Patents by Inventor Andrew C. Chan

Andrew C. Chan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOGLOBULIN VARIANTS AND USES THEREOF
    Publication number: 20220002430
    Abstract: The invention provides humanized and chimeric anti-CD20 antibodies for treatment of CD20 positive malignancies and autoimmune diseases.
    Type: Application
    Filed: April 20, 2021
    Publication date: January 6, 2022
    Applicant: Genentech, Inc.
    Inventors: Camellia W. ADAMS, Andrew C. CHAN, Craig W. CROWLEY, Henry B. LOWMAN, Gerald R. NAKAMURA, Leonard G. PRESTA
  • IMMUNOGLOBULIN VARIANTS AND USES THEREOF
    Publication number: 20190071511
    Abstract: The invention provides humanized and chimeric anti-CD20 antibodies for treatment of CD20 positive malignancies and autoimmune diseases.
    Type: Application
    Filed: February 26, 2018
    Publication date: March 7, 2019
    Applicant: Genentech, Inc.
    Inventors: Camellia W. ADAMS, Andrew C. CHAN, Craig W. CROWLEY, Henry B. LOWMAN, Gerald R. NAKAMURA, Leonard G. PRESTA
  • IMMUNOGLOBULIN VARIANTS AND USES THEREOF
    Publication number: 20170158773
    Abstract: The invention provides humanized and chimeric anti-CD20 antibodies for treatment of CD20 positive malignancies and autoimmune diseases.
    Type: Application
    Filed: July 22, 2016
    Publication date: June 8, 2017
    Inventors: Camellia W. ADAMS, Andrew C. CHAN, Craig W. CROWLEY, Henry B. LOWMAN, Gerald R. NAKAMURA, Leonard G. PRESTA
  • IMMUNOGLOBULIN VARIANTS AND USES THEREOF
    Publication number: 20140154242
    Abstract: The invention provides humanized and chimeric anti-CD20 antibodies for treatment of CD20 positive malignancies and autoimmune diseases.
    Type: Application
    Filed: September 17, 2013
    Publication date: June 5, 2014
    Applicant: Genentech, Inc.
    Inventors: Camellia W. ADAMS, Andrew C. Chan, Craig W. Crowley, Henry B. Lowman, Gerald R. Nakamura, Leonard G. Presta
  • Immunoglobulin variants and uses thereof
    Patent number: 8562992
    Abstract: The invention provides humanized and chimeric anti-CD20 antibodies for treatment of CD20 positive malignancies and autoimmune diseases.
    Type: Grant
    Filed: October 22, 2008
    Date of Patent: October 22, 2013
    Assignee: Genentech, Inc.
    Inventors: Camellia W. Adams, Andrew C. Chan, Craig W. Crowley, Henry B. Lowman, Gerald R. Nakamura, Leonard G. Presta
  • Immunoglobulin variants and uses thereof
    Patent number: 7799900
    Abstract: The invention provides humanized and chimeric anti-CD20 antibodies for treatment of CD20 positive malignancies and autoimmune diseases.
    Type: Grant
    Filed: June 7, 2005
    Date of Patent: September 21, 2010
    Assignee: Genentech, Inc.
    Inventors: Camellia W. Adams, Andrew C. Chan, Craig W. Crowley, Henry B. Lowman, Gerald R. Nakamura, Leonard G. Presta
  • Anti-Fc-gamma receptor antibodies, bispecific variants and uses therefor
    Patent number: 7662926
    Abstract: The present application describes antibodies that selectively bind human Fc?RIIB, with little or no binding to other human Fc?Rs, e.g., human Fc?RIIA. The invention also provides isolated bispecific antibodies comprising an antibody that selectively binds Fc?RIIB, and a second antibody that specifically binds an activating receptor. Various uses, including therapeutic uses, for those antibodies are also described, including administration with anti-tumor antibodies and methods of inhibiting immune responses and suppressing histamine release.
    Type: Grant
    Filed: January 18, 2007
    Date of Patent: February 16, 2010
    Assignee: Genentech, Inc.
    Inventors: Andrew C. Chan, Robert L. Shields, Lawren Wu
  • Anti-FC-gamma RIIB receptor antibody and uses therefor
    Patent number: 7655229
    Abstract: The present application describes antibodies that selectively bind human Fc?RIIB, with little or no binding to other human Fc?Rs, e.g., human Fc?RIIA. The invention also provides isolated bispecific antibodies comprising an antibody that selectively binds Fc?RIIB, and a second antibody that specifically binds an activating receptor. Various uses, including therapeutic uses, for those antibodies are also described, including administration with anti-tumor antibodies and methods of inhibiting immune responses and suppressing histamine release.
    Type: Grant
    Filed: April 16, 2007
    Date of Patent: February 2, 2010
    Inventors: Andrew C. Chan, Robert L. Shields, Lawren Wu
  • NOVEL COMPOSITION AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES
    Publication number: 20090181024
    Abstract: The present invention relates to compositions containing a novel protein and methods of using those compositions for the diagnosis and treatment of immune related diseases.
    Type: Application
    Filed: September 29, 2006
    Publication date: July 16, 2009
    Applicant: Genentech, Inc.
    Inventors: Daryl T. Baldwin, Sarah C. Bodary, Andrew C. Chan, Hilary Clark, Janet K. Jackman, William I. Wood
  • IMMUNOGLOBULIN VARIANTS AND USES THEREOF
    Publication number: 20090155257
    Abstract: The invention provides humanized and chimeric anti-CD20 antibodies for treatment of CD20 positive malignancies and autoimmune diseases.
    Type: Application
    Filed: October 22, 2008
    Publication date: June 18, 2009
    Applicant: GENENTECH, INC.
    Inventors: CAMELLIA W. ADAMS, ANDREW C. CHAN, CRAIG W. CROWLEY, HENRY B. LOWMAN, GERALD R. NAKAMURA, LEONARD G. PRESTA
  • ANTI-FC-GAMMA RIIB RECEPTOR ANTIBODY AND USES THEREFOR
    Publication number: 20090087428
    Abstract: The present application describes antibodies that selectively bind human Fc?RIIB, with little or no binding to other human Fc?Rs, e.g., human Fc?RIIA. The invention also provides isolated bispecific antibodies comprising an antibody that selectively binds Fc?RIIB, and a second antibody that specifically binds an activating receptor. Various uses, including therapeutic uses, for those antibodies are also described, including administration with anti-tumor antibodies and methods of inhibiting immune responses and suppressing histamine release.
    Type: Application
    Filed: January 18, 2007
    Publication date: April 2, 2009
    Inventors: Andrew C. Chan, Robert L. Shields, Lawren Wu
  • Treatment Method
    Publication number: 20080299117
    Abstract: The invention provides methods of treating autoimmune diseases using lower doses of anti-CD20 antibodies of 100 mg to 200 mg effective to deplete B cells in the patient.
    Type: Application
    Filed: May 21, 2008
    Publication date: December 4, 2008
    Inventors: Hal V. Barron, Andrew C. Chan, Daniel Combs, Wolfgang Dummer, Paul J. Fielder, Gwendolyn Fyfe
  • Novel composition and methods for the treatment of immune related diseases
    Publication number: 20040121370
    Abstract: The present invention relates to compositions containing a novel protein and methods of using those compositions for the diagnosis and treatment of immune related diseases.
    Type: Application
    Filed: September 9, 2003
    Publication date: June 24, 2004
    Applicant: Genentech, Inc.
    Inventors: Daryl T. Baldwin, Sarah C. Bodary, Andrew C. Chan, Hilary Clark, Janet K. Jackman, William I. Wood
  • BLNK proteins
    Patent number: 6638724
    Abstract: The invention relates to novel BLNK proteins, nucleic acids and antibodies.
    Type: Grant
    Filed: July 23, 1999
    Date of Patent: October 28, 2003
    Assignee: Washington University
    Inventors: Andrew C. Chan, Chong Fu
  • BLNK proteins
    Patent number: 5994522
    Abstract: The invention relates to novel BLNK proteins, nucleic acids and antibodies.
    Type: Grant
    Filed: March 17, 1997
    Date of Patent: November 30, 1999
    Assignee: Washington University
    Inventors: Andrew C. Chan, Chong Fu
  • Composition and methods for the diagnosis of immune related diseases involving the PRO52254 polypeptide
    Patent number: RE46534
    Abstract: The present invention relates to compositions containing a novel protein and methods of using those compositions for the diagnosis and treatment of immune related diseases involving detection of the PRO52254 polypeptide.
    Type: Grant
    Filed: April 29, 2015
    Date of Patent: September 5, 2017
    Assignee: Genentech, Inc.
    Inventors: Daryl T. Baldwin, Sarah C. Bodary-Winter, Andrew C. Chan, Hilary Clark, Janet K. Jackman, William I. Wood
  • Composition and methods for the diagnosis of immune related diseases involving the PRO52254 polypeptide
    Patent number: RE46805
    Abstract: The present invention relates to compositions containing a novel protein and methods of using those compositions for the diagnosis and treatment of immune related diseases involving detection of the PRO52254 polypeptide.
    Type: Grant
    Filed: March 27, 2014
    Date of Patent: April 24, 2018
    Assignee: Genentech, Inc.
    Inventors: Daryl T. Baldwin, Sarah C. Bodary-Winter, Andrew C. Chan, Hilary Clark, Janet K. Jackman, William I. Wood
  • Composition and methods for the diagnosis of immune related diseases involving the PRO52254 polypeptide
    Patent number: RE46816
    Abstract: The present invention relates to compositions containing a novel protein and methods of using those compositions for the diagnosis and treatment of immune related diseases involving detection of the PRO52254 polypeptide.
    Type: Grant
    Filed: March 27, 2014
    Date of Patent: May 1, 2018
    Assignee: Genentech, Inc.
    Inventors: Daryl T. Baldwin, Sarah C. Bodary-Winter, Andrew C. Chan, Hilary Clark, Janet K. Jackman, William I. Wood